May 23, 2013 11:19 AM ET

Biotechnology

Company Overview of Ignyta, Inc.

Company Overview

Ignyta, Inc., a biotechnology company, engages in catalyzing personalized medicine in autoimmune diseases. The company discovers, develops, validates, and commercializes diagnostic tests and therapeutic drugs for rheumatoid arthritis (RA) and other autoimmune diseases. It offers Methylome, a computational platform that helps accelerate the discovery of biomarkers for diagnostic and therapeutic purposes. Ignyta, Inc. was formerly known as NexDx, Inc. and changed its name to Ignyta, Inc. in October 2012. The company was founded in 2011 and is based in San Diego, California.

11575 Sorrento Valley Road

Suite 200

San Diego, CA 92121

United States

Founded in 2011

Phone:

858-436-1330

Fax:

858-436-1349

www.nexdx.com

Key Executives for Ignyta, Inc.

Co-Founder
Age: 40
Co-Founder and Scientific Advisor
Head of Bioinformatics
Vice President of Corporate Development
Director of Molecular Biology and Biochemistry
Age: 54
Compensation as of Fiscal Year 2012.

Ignyta, Inc. Key Developments

Ignyta, Inc. Appoints Tom Huizinga to Scientific Advisory Board

Ignyta, Inc. announced the appointment of Professor Tom Huizinga, Chairman of the Department of Rheumatology at Leiden University Medical Center to its Scientific Advisory Board.

Ignyta, Inc. Raises Additional $1 Million Through Capital Term Loan from Silicon Valley Bank

Ignyta, Inc. announced that Silicon Valley Bank (SVB) has expanded its support of Ignyta through an additional $1 million capital term loan facility. The new facility is incremental to the previous $500,000 facility entered into between Ignyta and SVB in June 2012.

Ignyta Signs Rheumatoid Arthritis Research Collaboration with Leiden University Medical Center

Ignyta, Inc. announced a collaboration with Leiden University Medical Center (LUMC) to assess the epigenetic signatures of patients with early synovitis and rheumatoid arthritis.

Similar Private Companies By Industry

Company Name Region
HµREL Corporation United States
Principia Pharmaceuticals Corporation United States
Enzium, Inc. United States
Schepens Eye Research Institute Inc. United States
BioValve Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 22, 2012
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ignyta, Inc., please visit www.nexdx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.